SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001114220-18-000077
Filing Date
2018-07-12
Accepted
2018-07-12 18:00:40
Documents
1
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_153143282475924.html 4  
1 FORM 4 wf-form4_153143282475924.xml 4 5606
  Complete submission text file 0001114220-18-000077.txt   6974
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Enyedy Mark J (Reporting) CIK: 0001586965 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 18951307